Real-world data confirms limited efficacy of dual programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 immune checkpoint blockade in acral lentiginous melanoma

真实世界数据证实，双重程序性细胞死亡蛋白1和细胞毒性T淋巴细胞相关蛋白4免疫检查点阻断疗法在肢端雀斑样黑色素瘤中疗效有限。